Search results for "cell therapy"

showing 10 items of 117 documents

A new method to value efficiency of enzyme blends for pancreas tissue digestion

2010

In pancreatic islets isolation for cell therapy the major enzymes used are obtained from Clostridium hystoliticum: class I and class II collagenases. They are used in a defined tissue dissociation enzyme mixture together with neutral protease (Dispase) or thermolysin (Thermostable Neutral Protease). However, just to now, people working in islets production found variable outcomes in isolation procedures mainly due to large variability in enzymatic blend composition and efficacy. Using electrophoresis and gelatin zymography approaches together with densitometry evaluation assays we compared the composition, stability and auto-digestion processes of C. hystoliticum collagenases, Neutral prote…

Settore BIO/10 - BiochimicaPancreatic enzyme cell therapy collagenases.
researchProduct

Wharton's jelly mesencymal stem cells differentiated into hepatocyte-like cells show expression of immunomodulatory molecules

2014

Settore BIO/16 - Anatomia UmanaWharton's jelly mesenchymal stem cells umbilical cord cell therapy regenerative medicine immunomodulatory molecules
researchProduct

Novel Immunomodulatory Markers Expressed by Human WJ-MSC: an Updated Review in Regenerative and Reparative Medicine.

2012

Mesenchymal (stromal) stem cells (MSC) are a broad class of stromal populations which are able to differentiate towards mature cell types, and do express molecules involved in immune modulation, tolerance induction and inflammation dampening. MSC can be virtually isolated from each adult organ, as well as from foetus-associated perinatal tissues. In particular, Wharton's jelly-derived MSC (WJ-MSC) bear all of these key properties, together with their ease of sourcing and lack of ethical issues. Cellular therapy is a key technique in regenerative medicine approaches, in particular for the treatment of diseases in which physiological processes of cellular repopulation are blocked by the under…

Stromal cellCellular differentiationImmune modulationRegenerative medicineCell therapyDevelopmental NeuroscienceMedicineProgenitor cellTissue repairUmbilical cordMesenchymal stem cellInflammationbusiness.industrySettore BIO/16 - Anatomia UmanaWharton's jellyMesenchymal stem cellMatrix metalloproteinaseTolerance inductionDifferentiationHypoimmunogenicityImmunologyRegenerative medicineStem cellbusinessNeuroscienceDevelopmental Biology
researchProduct

Biomaterials coated by dental pulp cells as substrate for neural stem cell differentiation

2011

[EN] This study is focused on the development of an in vitro hybrid system, consisting in a polymeric biomaterial covered by a dental pulp cellular stroma that acts as a scaffold offering a neurotrophic support for the subsequent survival and differentiation of neural stem Cells. In the first place, the behavior of dental pulp stroma on the polymeric biomaterial based on ethyl acrylate and hydroxy ethyl acrylate copolymer was studied. For this purpose, cells from normal human third molars were grown onto 0.5-mm-diameter biomaterial discs. After cell culture, quantification of neurotrophic factors generated by the stromal cells was performed by means of an ELISA assay. In the second place, s…

Stromal cellMaterials scienceBiomedical EngineeringBiomaterialsCell therapyMiceNerve growth factorCoated Materials BiocompatibleNeural Stem Cellsstomatognathic systemNeurotrophic factorsAnimalsHumansNeural cellCells CulturedDental PulpCell ProliferationNeuronsStem cellBrain-Derived Neurotrophic FactorMetals and AlloysBiomaterialCell adhesionCell DifferentiationNeural stem cellRatsCell biologystomatognathic diseasesCell cultureMAQUINAS Y MOTORES TERMICOSCeramics and CompositesCell cultureStem cellNeural cellBiomedical engineering
researchProduct

Optogenetics in Stem Cell Research: Focus on the Central Nervous System

2017

Stem cell-based therapies of CNS disorders represent a promising approach in translational and regenerative medicine. Stem cell-based tissue replacement and regeneration would, for the first time, offer a causal treatment strategy which is most likely not bound to a specific time window. Therapeutic strategies relying on this paradigm would require administration of exogenous stem cells to the CNS and/or the augmentation of endogenous stem cell capabilities. However, it remains unclear whether tissue replacement or bystander effects are required to induce such effects. Conventional experimental techniques will not be able to causally reveal such information, due to the complexity and coinci…

TransplantationCell typeMechanism (biology)medicine.medical_treatmentRegeneration (biology)medicineStem-cell therapyStem cellBiologyOptogeneticsRegenerative medicineNeuroscience
researchProduct

Improving the Techniques for Human Hepatocyte Transplantation: Report from a Consensus Meeting in London

2012

On September 6 and 7, 2009 a meeting was held in London to identify and discuss what are perceived to be current roadblocks to effective hepatocyte transplantation as it is currently practiced in the clinics and, where possible, to offer suggestions to overcome the blocks and improve the outcomes for this cellular therapy. Present were representatives of most of the active clinical hepatocyte transplant programs along with other scientists who have contributed substantial basic research to this field. Over the 2-day sessions based on the experience of the participants, numerous roadblocks or challenges were identified, including the source of cells for the transplants and problems with tra…

Transplantationbusiness.industryCellular differentiationMesenchymal stem celllcsh:RBiomedical Engineeringlcsh:MedicineCell Biologymedicine.diseaseBioinformaticsLiver regenerationCell therapyTransplantationLiver diseasemedicine.anatomical_structureHepatocyteImmunologymedicineStem cellbusiness
researchProduct

Energy Metabolism Analysis of Three Different Mesenchymal Stem Cell Populations of Umbilical Cord Under Normal and Pathologic Conditions

2020

AbstractHuman umbilical cord mesenchymal stem cells (hUC-MSCs) are a pivotal source of therapeutically active cells for regenerative medicine due to their multipotent differentiation potential, immunomodulatory and anti-inflammatory proprieties, as well as logistical collection advantages without ethical concerns. However, it remains poorly understood whether MSCs from different compartments of the human umbilical cord are therapeutically superior than others. In this study, MSCs were isolated from Wharton’s jelly (WJ-MSCs), perivascular region (PV-MSCs) and cord lining (CL-MSCs) of hUC. These cells expressed the mesenchymal markers (CD90, CD73), stemness marker (OCT4), endothelial cell adh…

Wharton’s JellyCell Survivalmedicine.medical_treatmentBioenergeticIschemic diseaseBiologyBioenergeticsUmbilical cordArticleUmbilical CordIschemic diseasesWharton's jellymedicineHumansUmbilical cord mesenchymal stem cellWharton JellyPerivascularCell ShapeStem cell therapyUmbilical cord mesenchymal stem cellsMesenchymal stem cellMesenchymal Stem CellsStem-cell therapyCord liningCell biologyMitochondriaEndothelial stem cellStrokemedicine.anatomical_structureCD146Stem cellEnergy MetabolismBiomarkers
researchProduct

How is the biocompatibilty of dental biomaterials evaluated?

2007

All biomaterials used in dentistry must be evaluated for biocompatibility using screening assays to protect patient health and safety. The purpose of this review is to explain the international biocompatibility guidelines, and to explain the structure of a test program. The test program requires the structured assessment of materials into four phases; general toxicity, local tissue irritation, pre-clinical, and clinical evaluation. Different types of screening assays are available, and it is important to understand the advantages and limitations of the various types of assays that are available, so that they can be selected for appropriateness and interpreted accurately. New scientific adva…

biocompatibilityCytotoxicitytissue engineeringUNESCO::CIENCIAS MÉDICASgrowth factorsdental materials:CIENCIAS MÉDICAS [UNESCO]gene therapystem cell therapy
researchProduct

Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs).

2019

Adipose tissue is now on the top one of stem cell sources regarding its accessibility, abundance, and less painful collection procedure when compared to other sources. The adipose derived stem cells (ADSCs) that it contains can be maintained and expanded in culture for long periods of time without losing their differentiation capacity, leading to large cell quantities being increasingly used in cell therapy purposes. Many reports showed that ADSCs-based cell therapy products demonstrated optimal efficacy and efficiency in some clinical indications for both autologous and allogeneic purposes, hence becoming considered as potential tools for replacing, repairing, and regenerating dead or dama…

bone marrowmedicine.medical_treatmentAdipose tissueregenerative medicineBone Marrow CellsReviewMesenchymal Stem Cell TransplantationRegenerative medicinestem cell therapyCatalysisUmbilical CordInorganic ChemistryCell therapylcsh:ChemistryADSCsMedicineAnimalsHumansPhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5Spectroscopymesenchymal stem cellsbusiness.industryOrganic ChemistryMesenchymal stem cellCell DifferentiationGeneral MedicineStem-cell therapyStromal vascular fractionComputer Science Applicationsadipose tissueadipose derived stem cellsmedicine.anatomical_structurelcsh:Biology (General)lcsh:QD1-999Cancer researchBone marrowStem cellbusinessInternational journal of molecular sciences
researchProduct

Evolution of the Regulatory Landscape for Immunomodulatory Compounds and Personalized Therapeutic Cancer Vaccines

2014

The term cancer immunotherapy covers a huge range of different therapeutic interventions based on highly diverse medicinal products. Some immunotherapy products such as monoclonal antibodies have successfully been developed during the last years and contributed to major advances in cancer therapy. Development of cancer vaccines seemed to be more challenging. Nevertheless, some promising candidates are currently in late-stage clinical development, and one product (sipuleucel-T) was recently approved in the United States (USA) and in the European Union (EU). Additionally, cell therapy approaches based on adoptive lymphocyte transfer have recently come into focus due to surprisingly efficient …

business.industrymedicine.medical_treatmentCancer therapyCancerImmunotherapyBiologymedicine.diseaseBioinformaticsBiotechnologyCell therapySafety profileCancer immunotherapymedicinemedia_common.cataloged_instanceCancer vaccineEuropean unionbusinessmedia_common
researchProduct